Volume 6, Issue 1

• Several New Partnerships for Drug Development in Schizophrenia
  Author(s): Peter F. Buckley
  • PDF
• Varenicline Precipitating Psychosis in a Patient with no Previous Psychiatric History: A Case Report of a Spanish Patient Who was Later Diagnosed with Paranoid Personality Disorder
  Author(s): Fernando Espi Forcen, Fernando Luis Espi Martinez, Amparo Martinez Moya
  • Abstract
  • PDF
• Asenapine: A Synthesis of Efficacy Data in Bipolar Mania and Schizophrenia
  Author(s): Roger S. McIntyre, Rosary Wong
  • Abstract
  • PDF
• Adjunct Treatments for Schizophrenia and Bipolar Disorder: What to Try When You Are Out of Ideas
  Author(s): E. Fuller Torrey, John M. Davis
  • Abstract
• Monitoring Metabolic Side Effects when Initiating Treatment with Second-Generation Antipsychotic Medication
  Author(s): Ellen Weissman, Carlos Jackson, Nina Schooler, Ray Goetz, Susan Essock
  • Abstract
  • PDF
• Sustaining Full Recovery in Schizophrenia after 15 Years: Does Resilience Matter?
  Author(s): Anne-Kari Torgalsbøen
  • Abstract
  • PDF
• Ziprasidone�??s Effect on Metabolic Markers in Patients with Diabetes and Chronic Schizophrenia
  Author(s): Ziprasidone, Diabetes, Switch, Schizophrenia, Schizoaffective Disorder, Metabolic Syndrome
  • Abstract